223 related articles for article (PubMed ID: 36454214)
1. Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis.
Wang Z; Yemanyi F; Blomfield AK; Bora K; Huang S; Liu CH; Britton WR; Cho SS; Tomita Y; Fu Z; Ma JX; Li WH; Chen J
Elife; 2022 Dec; 11():. PubMed ID: 36454214
[TBL] [Abstract][Full Text] [Related]
2. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling mediates pathological vascular growth in proliferative retinopathy.
Chen J; Stahl A; Krah NM; Seaward MR; Dennison RJ; Sapieha P; Hua J; Hatton CJ; Juan AM; Aderman CM; Willett KL; Guerin KI; Mammoto A; Campbell M; Smith LE
Circulation; 2011 Oct; 124(17):1871-81. PubMed ID: 21969016
[TBL] [Abstract][Full Text] [Related]
4. Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice.
Chen J; Stahl A; Krah NM; Seaward MR; Joyal JS; Juan AM; Hatton CJ; Aderman CM; Dennison RJ; Willett KL; Sapieha P; Smith LE
PLoS One; 2012; 7(1):e30203. PubMed ID: 22272305
[TBL] [Abstract][Full Text] [Related]
5. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
6. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer.
Shen X; Wang G; He H; Shang P; Yan B; Wang X; Shen W
Breast Cancer; 2024 Jan; 31(1):96-104. PubMed ID: 37914960
[TBL] [Abstract][Full Text] [Related]
7. Endothelial TWIST1 promotes pathological ocular angiogenesis.
Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
[TBL] [Abstract][Full Text] [Related]
8. LRP5 is required for vascular development in deeper layers of the retina.
Xia CH; Yablonka-Reuveni Z; Gong X
PLoS One; 2010 Jul; 5(7):e11676. PubMed ID: 20652025
[TBL] [Abstract][Full Text] [Related]
9. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
[TBL] [Abstract][Full Text] [Related]
10. RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.
Sun Y; Liu CH; Wang Z; Meng SS; Burnim SB; SanGiovanni JP; Kamenecka TM; Solt LA; Chen J
FASEB J; 2017 Oct; 31(10):4492-4502. PubMed ID: 28646017
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of SLC38A5, an amino acid-coupled Na+/H+ exchanger, in triple-negative breast cancer and its relevance to macropinocytosis.
Ramachandran S; R Sennoune S; Sharma M; Thangaraju M; V Suresh V; Sneigowski T; D Bhutia Y; Pruitt K; Ganapathy V
Biochem J; 2021 Nov; 478(21):3957-3976. PubMed ID: 34704597
[TBL] [Abstract][Full Text] [Related]
12. MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy.
Xu Z; Gong J; Maiti D; Vong L; Wu L; Schwarz JJ; Duh EJ
Am J Pathol; 2012 Jun; 180(6):2548-60. PubMed ID: 22521302
[TBL] [Abstract][Full Text] [Related]
13. The
Taurino G; Chiu M; Bianchi MG; Griffini E; Bussolati O
Am J Physiol Cell Physiol; 2023 Aug; 325(2):C550-C562. PubMed ID: 37458433
[No Abstract] [Full Text] [Related]
14. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract][Full Text] [Related]
15. Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer.
Sniegowski T; Rajasekaran D; Sennoune SR; Sunitha S; Chen F; Fokar M; Kshirsagar S; Reddy PH; Korac K; Mahmud Syed M; Sharker T; Ganapathy V; Bhutia YD
Sci Rep; 2023 Oct; 13(1):16863. PubMed ID: 37803043
[TBL] [Abstract][Full Text] [Related]
16. Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.
Miyazaki T; Taketomi Y; Saito Y; Hosono T; Lei XF; Kim-Kaneyama JR; Arata S; Takahashi H; Murakami M; Miyazaki A
Circ Res; 2015 Mar; 116(7):1170-81. PubMed ID: 25648699
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-specific deletion of Nox4 delays retinal vascular development and mitigates pathological angiogenesis.
Tang X; Wang JJ; Wang J; Abboud HE; Chen Y; Zhang SX
Angiogenesis; 2021 May; 24(2):363-377. PubMed ID: 33201372
[TBL] [Abstract][Full Text] [Related]
19. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
20. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
Weskamp G; Mendelson K; Swendeman S; Le Gall S; Ma Y; Lyman S; Hinoki A; Eguchi S; Guaiquil V; Horiuchi K; Blobel CP
Circ Res; 2010 Mar; 106(5):932-40. PubMed ID: 20110534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
